表紙
市場調查報告書
商品編碼
1027102

全球血液和血液成分市場:按產品類型、按應用、按最終用戶、按地區規模、份額、展望、機會分析(2021-2028)

Blood and Blood Components Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球血液和血液成分市場的規模取決於出血和慢性疾病的增加、旨在開發治療出血疾病的新技術的研發活動的激活以及在市場上運營的主要公司. 增長預計將受到越來越多地採用合併、收購、聯盟和合作等增長戰略的推動。

本報告調查了全球血液和血液成分市場,並提供了有關市場前景、市場動態、趨勢分析、市場分析、競爭狀況等方面的全面信息。

目錄

第 1 章調查目標/先決條件

第二章市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
    • 市場細分:按產品類型
    • 市場細分:按應用
    • 市場細分:按最終用戶
    • 市場細分:按地區
  • 相干機會圖 (COM)

第 3 章市場動態、法規、趨勢分析

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
  • 影響分析
  • 管道分析
  • PEST 分析
  • 監管場景
  • 市場趨勢
  • 主要亮點
  • 兌換場景
  • 併購

第 4 章全球血液和血液成分市場-冠狀病毒 (COVID-19) 大流行的影響

  • 經濟影響
  • 對臨床試驗和藥物開發的影響
  • 政府倡議

第 5 章全球血液和血液成分市場:按產品類型(2017-2028)(百萬美元)

  • 簡介
  • 全血
  • 血液成分
  • 紅細胞
  • 白細胞
  • 血小板
  • 等離子

第 6 章全球血液和血液成分市場:按應用(2017-2028)(100 萬美元)

  • 簡介
  • 貧血
  • 創傷和手術
  • 癌症治療
  • 出血性疾病
  • 其他(包括罕見病)

第 7 章全球血液和血液成分市場:按最終用戶(2017-2028)(百萬美元)

  • 簡介
  • 醫院
  • 門診手術中心
  • 血液和血液成分庫
  • 其他

第 8 章全球血液和血液成分市場:按地區(2017-2028 年)(100 萬美元)

  • 簡介
  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章競爭形勢

  • 熱圖分析
  • 市場份額分析
    • Becton, Dickinson &Co.
    • Kidde-Fenwal Inc.
    • Bio-Rad Laboratories, Inc.
    • Cerus Corporation
    • Immucor
    • Beckman Coulter, Inc.
    • bioMerieux SA
    • Octapharma AG
    • Abbott
    • CSL Behring LLC
    • MacoPharma
    • Shanghai RAAS
    • China Biologic Products Holdings, Inc.
    • Takeda Pharmaceutical Company Limited
    • Grifols SA
    • Bharat Serums and Vaccines Ltd.
    • Terumo BCT Inc.
  • 分析師見解

第10章 章節

目錄
Product Code: CMI4574

Blood is a specialized bodily fluid that circulates through the entire body with the help of a network of blood vessels such as arteries, veins, and capillaries. Blood is made up of four major components, which include red blood cells, white blood cells, plasma, and platelets. Red blood cells, also known as erythrocytes or RBC account for the major portion of blood cells. RBC have a specialized red colored pigment called hemoglobin, which is responsible for carrying oxygen rich blood from the lungs to the rest of the body and deoxygenated blood from the body to the lungs. The average life cycle of RBC is 120 days after which they are removed by the spleen. White blood cells, also known as leukocytes are responsible for making the immune system of the body and help fight against microbial infections. Plasma is the liquid component of blood and is a mixture of water, protein, sugar, salts, and fat. Platelets, also known as thrombocytes help in clotting of blood at the site of tissue injury. Whole blood consists of 45% blood cells and 55% plasma.

According to the American Society of Hematology, blood makes up around 7 to 8% of human body weight. Blood and blood components are used for blood transfusion in case of blood loss during a traumatic injury, hemorrhage to maintain blood volume during cancer treatment, and to treat bleeding disorders.

Market Dynamics

The increasing incidence of bleeding disorders and chronic diseases, rising research and development activities for the development of novel technology for the treatment of bleeding disorders, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global blood and blood components market over the forecast period.

For instance, according to the statistics provided by the World Federation of Hemophilia (WFH) in 2018, over 400,000 people suffered from hemophilia of which around 173,000 people were diagnosed with hemophilia A or B in 2017, across the globe.

Key features of the study:

  • This report provides in-depth analysis of the global blood and blood components market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global blood and blood components market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton, Dickinson & Co., Kidde-Fenwal Inc., Bio-Rad Laboratories, Inc., Cerus Corporation, Immucor, Beckman Coulter, Inc., bioMerieux SA, Octapharma AG, Abbott, CSL Behring LLC, MacoPharma, Shanghai RAAS, China Biologic Products Holdings, Inc., Takeda Pharmaceutical Company Limited, Grifols S.A., Bharat Serums and Vaccines Ltd., and Terumo BCT Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global blood and blood components market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood and blood components market

Detailed Segmentation:

  • Global Blood and Blood Components Market, By Product Type:
    • Whole Blood
    • Blood Components
  • Red Blood Cells
  • White Blood Cells
  • Platelets
  • Plasma
  • Global Blood and Blood Components Market, By Application:
    • Anemia
    • Trauma and Surgery
    • Cancer Treatment
    • Bleeding Disorders
    • Others (Others include rare blood diseases)
  • Global Blood and Blood Components Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Blood and Blood Component Bank
    • Others
  • Global Blood and Blood Components Market, By Region:
    • North America
      • By Product Type
      • Whole Blood
      • Blood Components
    • Red Blood Cells
    • White Blood Cells
    • Platelets
    • Plasma
      • By Application
      • Anemia
      • Trauma and Surgery
      • Cancer Treatment
      • Bleeding Disorders
      • Others (Others include rare blood diseases)
      • By End User
      • Hospitals
      • Ambulatory Surgical Centers
      • Blood and Blood Component Bank
      • Others
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Product Type
      • Whole Blood
      • Blood Components
    • Red Blood Cells
    • White Blood Cells
    • Platelets
    • Plasma
      • By Application
      • Anemia
      • Trauma and Surgery
      • Cancer Treatment
      • Bleeding Disorders
      • Others (Others include rare blood diseases)
      • By End User
      • Hospitals
      • Ambulatory Surgical Centers
      • Blood and Blood Component Bank
      • Others
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type
      • Whole Blood
      • Blood Components
    • Red Blood Cells
    • White Blood Cells
    • Platelets
    • Plasma
      • By Application
      • Anemia
      • Trauma and Surgery
      • Cancer Treatment
      • Bleeding Disorders
      • Others (Others include rare blood diseases)
      • By End User
      • Hospitals
      • Ambulatory Surgical Centers
      • Blood and Blood Component Bank
      • Others
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type
      • Whole Blood
      • Blood Components
    • Red Blood Cells
    • White Blood Cells
    • Platelets
    • Plasma
      • By Application
      • Anemia
      • Trauma and Surgery
      • Cancer Treatment
      • Bleeding Disorders
      • Others (Others include rare blood diseases)
      • By End User
      • Hospitals
      • Ambulatory Surgical Centers
      • Blood and Blood Component Bank
      • Others
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type
      • Whole Blood
      • Blood Components
    • Red Blood Cells
    • White Blood Cells
    • Platelets
    • Plasma
      • By Application
      • Anemia
      • Trauma and Surgery
      • Cancer Treatment
      • Bleeding Disorders
      • Others (Others include rare blood diseases)
      • By End User
      • Hospitals
      • Ambulatory Surgical Centers
      • Blood and Blood Component Bank
      • Others
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type
      • Whole Blood
      • Blood Components
    • Red Blood Cells
    • White Blood Cells
    • Platelets
    • Plasma
      • By Application
      • Anemia
      • Trauma and Surgery
      • Cancer Treatment
      • Bleeding Disorders
      • Others (Others include rare blood diseases)
      • By End User
      • Hospitals
      • Ambulatory Surgical Centers
      • Blood and Blood Component Bank
      • Others
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Becton, Dickinson & Co.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Kidde-Fenwal Inc.
    • Bio-Rad Laboratories, Inc.
    • Cerus Corporation
    • Immucor
    • Beckman Coulter, Inc.
    • bioMerieux SA
    • Octapharma AG
    • Abbott
    • CSL Behring LLC
    • MacoPharma
    • Shanghai RAAS
    • China Biologic Products Holdings, Inc.
    • Takeda Pharmaceutical Company Limited
    • Grifols S.A.
    • Bharat Serums and Vaccines Ltd.
    • Terumo BCT Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Highlights
  • Reimbursement Scenario
  • Mergers & Acquisitions

4. Global Blood and Blood Components Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials and Drug Development
  • Government Initiatives

5. Global Blood and Blood Components Market, By Product Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Whole Blood
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Blood Components
  • Red Blood Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • White Blood Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Platelets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Plasma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Blood and Blood Components Market, By Application, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Anemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Trauma and Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Cancer Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Bleeding Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others (Others include rare blood diseases)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Blood and Blood Components Market, By End User, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Blood and Blood Component Bank
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Blood and Blood Components Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2028
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Becton, Dickinson & Co.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kidde-Fenwal Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cerus Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Immucor
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Beckman Coulter, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • bioMerieux SA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Octapharma AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CSL Behring LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MacoPharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shanghai RAAS
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • China Biologic Products Holdings, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Takeda Pharmaceutical Company Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Grifols S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bharat Serums and Vaccines Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Terumo BCT Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact